Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 40.50B | 41.03B | 39.29B | 36.60B | 35.67B | 36.80B |
Gross Profit | 7.83B | 8.36B | 6.55B | 7.47B | 7.27B | 7.48B |
EBITDA | 6.83B | 6.84B | 4.23B | 7.68B | 8.73B | 5.59B |
Net Income | 3.94B | 4.17B | 2.06B | 4.90B | 7.00B | 3.19B |
Balance Sheet | ||||||
Total Assets | 49.45B | 49.36B | 46.54B | 43.76B | 42.58B | 44.47B |
Cash, Cash Equivalents and Short-Term Investments | 1.90B | 4.35B | 3.11B | 2.58B | 3.53B | 4.91B |
Total Debt | 17.52B | 18.40B | 16.05B | 15.00B | 14.66B | 16.61B |
Total Liabilities | 33.98B | 34.07B | 31.75B | 28.44B | 29.65B | 33.89B |
Stockholders Equity | 15.47B | 15.29B | 14.79B | 15.31B | 12.93B | 10.58B |
Cash Flow | ||||||
Free Cash Flow | 1.31B | 2.62B | 2.10B | 1.47B | 2.15B | 2.88B |
Operating Cash Flow | 2.97B | 4.39B | 3.88B | 2.90B | 3.57B | 4.30B |
Investing Cash Flow | -1.35B | -1.75B | -1.58B | -1.24B | 2.06B | -1.21B |
Financing Cash Flow | -3.00B | -1.40B | -1.76B | -2.61B | -7.00B | -432.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $87.26B | 21.78 | 17.91% | 1.81% | 11.85% | 16.12% | |
78 Outperform | $51.47B | 30.72 | 8.90% | 1.73% | 2.93% | 43.29% | |
77 Outperform | $84.38B | 21.67 | 26.50% | 1.51% | -0.65% | 77.20% | |
76 Outperform | $211.50B | 34.72 | 10.13% | 1.65% | 15.44% | 164.00% | |
71 Outperform | $105.64B | 25.48 | 73.06% | 2.89% | 1.09% | -35.50% | |
64 Neutral | $10.73B | 15.65 | 7.58% | 2.01% | 2.80% | -14.92% | |
58 Neutral | $179.50B | ― | -162.23% | ― | 2.41% | -193.57% |
On September 2, 2025, Northrop Grumman Corporation entered into a new credit agreement to secure a five-year senior unsecured revolving credit facility worth $3 billion, replacing a previous $2.5 billion facility from August 2022. This facility is intended to support the company’s commercial paper program and general corporate purposes, with terms including covenants on asset sales and debt ratios, highlighting the company’s strategic financial management and stability in maintaining operational flexibility.